Arrowhead's Landmark Deal With Amgen Sends Shares Shooting Higher
September 29, 2016 at 12:25 PM EDT
Shares of Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) climbed as much as 15 percent to $8.09 after it announced a joint collaboration ...